BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14998310)

  • 1. Protection against brucellosis in goats, five years after vaccination with reduced-dose Brucella melitensis Rev 1 vaccine.
    Díaz-Aparicio E; Hernández L; Suárez-Güemes F
    Trop Anim Health Prod; 2004 Feb; 36(2):117-21. PubMed ID: 14998310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
    Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
    Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of brucellosis in Kuwait by vaccination of cattle, sheep and goats with Brucella abortus strain 19 or Brucella melitensis strain Rev. 1.
    al-Khalaf SA; Mohamad BT; Nicoletti P
    Trop Anim Health Prod; 1992 Feb; 24(1):45-9. PubMed ID: 1306918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.
    Blasco JM
    Prev Vet Med; 1997 Aug; 31(3-4):275-83. PubMed ID: 9234451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine Candidate Brucella melitensis 16M
    Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
    mSphere; 2020 May; 5(3):. PubMed ID: 32404509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence strain Rev. 1.
    Higgins JL; Bowen RA; Gonzalez-Juarrero M
    Vet Immunol Immunopathol; 2018 Aug; 202():74-84. PubMed ID: 30078602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
    el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A
    Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats.
    Díaz-Aparicio E; Marín C; Alonso-Urmeneta B; Aragón V; Pérez-Ortiz S; Pardo M; Blasco JM; Díaz R; Moriyón I
    J Clin Microbiol; 1994 May; 32(5):1159-65. PubMed ID: 8051240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival vaccination of young goats with Brucella melitensis strain Rev 1.
    Fensterbank R; Verger JM; Grayon M
    Ann Rech Vet; 1987; 18(4):397-403. PubMed ID: 3451685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of mass vaccination with a reduced dose of REV 1 vaccine for Brucella melitensis control in a population of small ruminants.
    Scharp DW; al Khalaf SA; al Muhanna MW; Cheema RA; Godana W
    Trop Anim Health Prod; 1999 Jun; 31(3):135-41. PubMed ID: 10445249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of ewes by a single conjunctival administration of Brucella melitensis Rev. 1 vaccine.
    Fensterbank R; Pardon P; Marly J
    Ann Rech Vet; 1985; 16(4):351-6. PubMed ID: 4091489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes.
    Verger JM; Grayon M; Zundel E; Lechopier P; Olivier-Bernardin V
    Vaccine; 1995 Feb; 13(2):191-6. PubMed ID: 7625115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival vaccination of pregnant ewes and goats with Brucella melitensis Rev 1 vaccine: safety and serological responses.
    Zundel E; Verger JM; Grayon M; Michel R
    Ann Rech Vet; 1992; 23(2):177-88. PubMed ID: 1610080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination control programs for multiple livestock host species: an age-stratified, seasonal transmission model for brucellosis control in endemic settings.
    Beauvais W; Musallam I; Guitian J
    Parasit Vectors; 2016 Jan; 9():55. PubMed ID: 26825313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field-oriented trial of the Chinese Brucella suis strain 2 vaccine on sheep and goats in Libya.
    Mustafa AA; Abusowa M
    Vet Res; 1993; 24(5):422-9. PubMed ID: 8260964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control and eradication of Brucella melitensis infection in sheep and goats.
    Blasco JM; Molina-Flores B
    Vet Clin North Am Food Anim Pract; 2011 Mar; 27(1):95-104. PubMed ID: 21215893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological assay after vaccination of goats with Brucella melitensis Rev. I and Brucella abortus 45/20 vaccines at Saudi Arabia.
    Taher SA; Ewais MA
    J Egypt Public Health Assoc; 1997; 72(3-4):379-94. PubMed ID: 17216995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.
    Higgins JL; Gonzalez-Juarrero M; Bowen RA
    PLoS One; 2017; 12(10):e0185823. PubMed ID: 29028813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.